Humboldt Fund is a venture capital fund that supports innovative, early-stage companies by investing in the biotech revolution. Synthetic biology is poised to transform the way we make chemicals, materials, foods and medicines. At Humboldt Fund, we identify and invest in pioneers of engineering, physical sciences and life sciences to bring emerging biotech enterprises to a global market. Together we explore, discover and create new technologies that disrupt global conventions and solve the critical issues of our world, while creating value and prosperity.
Employees: 1-10
Investment Type: Venture Capital
Investment Stage: Pre-Seed; Seed; Series A
Portfolio 13
| Date | Name | Website | Total Raised | Location |
| 09.01.2023 | Spiral The... | spiraltx.com | $8.25M | United Sta... |
| - | Meatable | meatable.com | $166.34M | Netherland... |
| - | MycoWorks | mycoworks.com | $187M | United Sta... |
| - | Mission Ba... | missionbarns.com | $24M | United Sta... |
| - | Finless Fo... | finlessfoods.com | $37.5M | United Sta... |
| - | Tierra Bio... | tierrabiosciences.com | $11.4M | United Sta... |
| - | ENDPOINT H... | endpoint.health | $52M | United Sta... |
| - | Cellino | cellinobio.com | $171M | United Sta... |
| - | The Not Co... | notco.com | $450M | Argentina,... |
| - | GC Therape... | gc-tx.com | $65M | United Sta... |
Show more
Mentions in press and media 12
| Date | Title | Description |
| 19.12.2025 | More grim news in cultivated meat sector as Meatable folds: ‘We are now entering the second phase of this industry’ | In a further blow to the nascent cultivated meat sector, Dutch cultivated meat startup Meatable is winding down operations after failing to secure funding, key shareholder Agronomics revealed this morning. A key shareholder in Meatable alon... |
| 15.12.2022 | 6 investors discuss why AI is more than just a buzzword in biotech | As ChatGPT has so aptly demonstrated, AI is now truly entering the mainstream consciousness. That’s why we weren’t very surprised when a slew of investors told us they rarely see a biotech startup that doesn’t incorporate AI in some form or... |
| 06.06.2022 | Governor Pritzker Announces $20 Million Investment in Humboldt Park Health | CHICAGO - Governor Pritzker joined Humboldt Park Health leaders to announce $20 million in funding for the safety-net hospital on the west side of Chicago, a product of the Governor's historic Rebuild Illinois infrastructure plan. $19 milli... |
| 10.02.2022 | New US Laboratory and funding for HAYA Therapeutics | |
| 17.09.2021 | Debut Biotech is creating next-gen ingredients through ‘cell-free biomanufacturing’ | With climate change and its environmental consequences upon us, many companies are turning to more ‘natural’ alternatives to the chemical-based ingredients commonly used in food, beverages, cosmetics, and therapeutics. One such company is S... |
| 12.08.2021 | Debut Biotech Raises $22.6M Series A to Commercialize High-Value Ingredients from Proprietary Cell-Free Biomanufacturing Platform | By overcoming the limitations of cell-based fermentation, Debut Biotech produces high-value ingredients rapidly and more sustainably. SAN DIEGO (PRWEB) August 12, 2021 Debut Biotech, a next generation biomanufacturing platform harnessing ce... |
| 25.03.2021 | Meatable banks $47m from DSM, others to realize the pluri-potential of its cellular pork & beef | Netherlands foodtech startup Meatable plans to expand its portfolio of cell-cultured pork and beef products following the close of its $47 million Series A round, co-founder and chief technology officer Daan Luining told AFN. New investors ... |
| 24.03.2021 | Dutch lab-grown meat startup Meatable raises €39.68M to bring its first products to market | Dutch lab-grown meat startup, Meatable, has raised $47M (approx €39.68M) in its Series A round of funding. With this, the company’s total funding has reached $60M (approx €50.66M), to date. The round was led by Dr. Rick Klausner, Section 32... |
| 17.11.2020 | MycoWorks banks $45m Series B funding; DCVC, AgFunder & celebs invest | MycoWorks, which produces an animal-free leather alternative, has raised $45 million in a Series B round co-led by Taiwan’s WTT Investment and California’s DCVC Bio. New investors included Valor Equity Partners, Humboldt Fund, and Gruss &am... |
| 12.11.2020 | BAYER AG Bayer : Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund | November 12, 2020 Metagenomi closes USD 65 million Series A financing led by Leaps by Bayer and Humboldt Fund Metagenomi is a genomic medicines company pioneering precision gene editing systems to advance curative therapies for oncology and... |
Show more